UK markets close in 7 hours 6 minutes

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.88+2.22 (+16.25%)
At close: 04:00PM EDT
15.97 +0.09 (+0.57%)
After hours: 07:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7788
Avg. Estimate-0.04-0.06-0.090.51
Low estimate-0.12-0.15-0.51-0.11
High estimate0.05-0.010.260.9
Year ago EPS-0.28-0.340.09-0.09
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7788
Avg. Estimate54.61M57.13M267.74M423.96M
Low estimate46M52.11M239.76M326.92M
High estimate59M61.1M342.75M511.4M
Year ago sales7.8M17.45M233.66M267.74M
Sales growth (year/est)599.90%227.40%14.60%58.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.37-0.250.12-0.1
Actual EPS-0.28-0.340.73-0.1
Difference0.09-0.090.610
Surprise %24.30%-36.00%508.30%0.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.04-0.06-0.090.51
7 days ago-0.04-0.06-0.090.53
30 days ago-0.04-0.07-0.110.48
60 days ago-0.06-0.06-0.090.55
90 days ago-0.1-0.07-0.120.43
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A11N/A
Up last 30 daysN/A231
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesTGTXIndustrySector(s)S&P 500
Current qtr.85.70%N/AN/AN/A
Next qtr.82.40%N/AN/AN/A
Current year-200.00%N/AN/AN/A
Next year666.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A